Evidence map›Paper›PMID 26297899›Full record

ArticleNeuroscience2015

Molecular and functional changes in glucokinase expression in the brainstem dorsal vagal complex in a murine model of type 1 diabetes.

K C Halmos, P Gyarmati, H Xu, S Maimaiti, G Jancsó, G Benedek, B N Smith

Abstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Cell reports methods · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Insights into the role of neuronal glucokinase.American journal of physiology. Endocrinology and metabolism · 2016
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

K C HalmosDepartment of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, United States; Department of Physiology, University of Szeged, Dom ter 10 H-6720, Szeged, Hungary.
P GyarmatiDepartment of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, United States.
H XuDepartment of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, United States.
S MaimaitiDepartment of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, United States.
G JancsóDepartment of Physiology, University of Szeged, Dom ter 10 H-6720, Szeged, Hungary.
G BenedekDepartment of Physiology, University of Szeged, Dom ter 10 H-6720, Szeged, Hungary.
B N SmithDepartment of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, United States. Electronic address: bret.smith@uky.edu.
University of Kentucky · USUniversity of Szeged · HU

Funding

Neural Circuitry in the Dorsal Vagal ComplexR01DK056132 · NIDDK · UNIVERSITY OF KENTUCKY · PI SMITH, BRET N · 2001 to 2019
$4.9M
NMDA modulation of diabetes-induced glutamate synaptic plasticityR21HD079256 · NICHD · UNIVERSITY OF KENTUCKY · PI SMITH, BRET N · 2014 to 2015
$405k
NICHD NIH HHS R21 HD079256NIDDK NIH HHS R01 DK056132
6 · The paper itself

Abstract

Glucose concentration changes in the nucleus tractus solitarius (NTS) affect visceral function and metabolism by influencing central vagal circuits, especially inhibitory, GABAergic NTS neurons. Acutely elevated glucose can alter NTS neuron activity, and prolonged hyperglycemia and hypoinsulemia in animal models of type 1 diabetes results in plasticity of neural responses in the NTS. NTS neurons contributing to metabolic regulation therefore act as central glucose sensors and are functionally altered in type 1 diabetes. Glucokinase (GCK) mediates cellular utilization of glucose, linking increased glucose concentration to excitability changes mediated by ATP-sensitive K(+) channels (KATP). Using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), Western blot, and in vitro electrophysiology, we tested the hypothesis that changes in GCK expression in the NTS accompany the development of diabetes symptoms in the streptozotocin (STZ)-treated mouse model of type 1 diabetes. After several days of hyperglycemia in STZ-treated mice, RNA expression of GCK, but not Kir6.2 or SUR1, was decreased versus controls in the dorsal vagal complex. Electrophysiological recordings in vitro indicated that neural responses to acute hyperglycemia, and synaptic responsiveness to blockade of GCK with glucosamine, were attenuated in GABAergic NTS neurons from STZ-treated mice, consistent with reduced molecular and functional expression of GCK in the vagal complex of hyperglycemic, STZ-treated mice. Altered autonomic responses to glucose in type 1 diabetes may therefore involve reduced functional GCK expression in the dorsal vagal complex.

Indexed as

Action PotentialsAnimalsDiabetes Mellitus, Type 1Disease Models, AnimalGABAergic NeuronsGlucokinaseGlucosamineGlucoseKATP ChannelsMaleMiceMice, TransgenicSolitary NucleusStreptozocinSynaptic PotentialsGlucokinaseGlucosamineGlucoseKATP ChannelsStreptozocinGABA neuronhyperglycemiaK(ATP) channelnucleus tractus solitariuspostsynaptic currentvagus

Identifiers

PMID26297899
PMCPMC4575893
OpenAlexW1737166113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.